EPISODE · Mar 7, 2019 · 8 MIN
CEO John Huemoeller of Axim Biotechnologies, Inc. (OTCQB: AXIM)
from Stock Day Media · host Stock Day Media
CEO John Huemoeller of Axim Biotechnologies, Inc. (OTCQB: AXIM), joins the show to talk about becoming the new CEO, how his business background will help in executing the new business plan, and bringing new pharmaceutical products to market. cannabinoid bioscience # discovery and commercialization # solid fiscal strategy # Clinical development programs # broad IP portfolio # reduced side effects # cannabinoid research and development # cannabis # patent # Cannaway # chewing gum Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO John Huemoeller of Axim Biotechnologies, Inc. (OTCQB: AXIM), joins the show to talk about becoming the new CEO, how his business background will help in executing the new business plan, and bringing new pharmaceutical products to market. cannabinoid bioscience # discovery and commercialization # solid fiscal strategy # Clinical development programs # broad IP portfolio # reduced side effects # cannabinoid research and development # cannabis # patent # Cannaway # chewing gum Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO John Huemoeller of Axim Biotechnologies, Inc. (OTCQB: AXIM)
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m